Researchers launch new study to test popular weight-loss drugs for long COVID treatment
Автор: Click On Detroit | Local 4 | WDIV
Загружено: 2025-11-11
Просмотров: 474
Описание: Researchers at Scripps Research are launching a digital clinical trial to explore the potential of GLP-1 drugs, already used for type 2 diabetes and obesity, in treating long COVID symptoms. The trial is accessible nationwide, except for Hawaii, and includes 1,000 participants in a randomized, double-blind, placebo-controlled design. Participants will engage in video check-ins and use a monitoring device, with outcomes potentially expanding to other infection-related conditions. Julia Moore Vogel, both a researcher and long COVID patient, highlights the hope and anecdotal evidence suggesting these drugs may provide additional health benefits.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
